Gentamicin is widely used in paediatric medicine and therapeutic monitoring
is mandatory due to the narrow margin of safety. Saliva sampling may be of
potential interest, especially in children in whom blood sampling is often
difficult. Experience with once daily intravenous administration of aminog
lycosides has grown in recent years. Gentamicin levels were measured in ser
um and saliva of 55 children treated with the drug (5 mg/kg per day), admin
istered intravenously in three different regimens: thrice (n = 19), twice (
n = 18), and once daily (n = 18). No correlation was found between serum ge
ntamicin concentrations and saliva levels when the drug was administered tw
ice or thrice daily, however, there was good correlation when the drug was
administered once daily (r(2) = 0.96, P < 0.0001).
Conclusion In children with uncomplicated infections treated with once dail
y gentamicin, trough concentrations of the drug can be monitored in saliva.